China Meheco Group Co (SHSE:600056) GF Score : 73/100 (As of May. 27, 2024)

View and export this data going back to 1997. Start your Free Trial

What is China Meheco Group Co GF Score?

China Meheco Group Co has the GF Score of 73, which implies that the company is Likely to have average performance.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 5/10
2. Profitability Rank : 6/10
3. Growth Rank : 6/10
4. GF Value Rank : 5/10
5. Momentum Rank : 3/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes China Meheco Group Co is Likely to have average performance.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of China Meheco Group Co's GF Score

For the Medical Distribution subindustry, China Meheco Group Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Meheco Group Co's GF Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China Meheco Group Co's GF Score distribution charts can be found below:

* The bar in red indicates where China Meheco Group Co's GF Score falls into.

China Meheco Group Co (SHSE:600056) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

China Meheco Group Co GF Score Related Terms

Thank you for viewing the detailed overview of China Meheco Group Co's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

China Meheco Group Co (SHSE:600056) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China Meheco Group Co Ltd (SHSE:600056) » Definitions » GF Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18 Guangming Zhongjie, Dongcheng District, Beijing, CHN, 100061

Website

http://www.meheco.com

China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, logistics to international trading, academic promotion and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products and others.

Executives

Qi Jian Xi	senior management
Ni Xiao Ling	Director

China Meheco Group Co (SHSE:600056) Headlines

No Headlines